SOUTH SAN FRANCISCO, Calif., June 6, 2007 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today announced that management will present at the Goldman Sachs 28th Annual Global Healthcare Conference on Tuesday, June 12th at 4:00 p.m. Pacific Time in Laguna Niguel, California.
A live audio webcast of the presentation will be open to all on our web site, www.paintrials.com. A replay will also be available through July 6, 2007.
About Pain Therapeutics, Inc.
We develop novel drugs for pain management and hematology/oncology. We have three investigational drug candidates in clinical programs. Remoxy(tm) and PTI-202 are proprietary, abuse-resistant forms of opioid drugs. Oxytrex(tm) is a novel, next-generation painkiller that potentially offers less physical dependence than currently marketed opioid painkillers. Our early-stage drugs include a novel radio-labeled monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. We are also working on a new treatment for patients with hemophilia, a rare blood disorder. The FDA has not yet evaluated the merits, safety or efficacy of our drug candidates. For more information, please visit our website at www.paintrials.com.